Research Article
Hematological and Biochemistry Profile and Risk Factors Associated with Pulmonary Tuberculosis Patients in Guyana
Table 4
Biochemistry parameters among TB and TB-HIV patients.
| | Reference value | HIV positive | HIV negative | | Mean ± SD | (95% CI) | Mean ± SD | (95% CI) |
| Indirect bilirubin (mg/dL) | 0.1–1.0 | 0.4 ± 0.3 | 0.4–0.6 | 0.41 ± 0.25 | 0.36–0.44 | T-bilirubin (mg/dL) | 0.2–1.2 | 0.7 ± 0.3 | 0.59–0.79 | 0.68 ± 0.7 | 0.58–0.77 | D-bilirubin (mg/dL) | 0.0–0.5 | 0.26 ± 0.2 | 0.20–0.31 | 0.24 ± 0.24 | 0.21–0.27 | AST (IU/L) | 5–34 | 64.6 ± 61.9 | 45.5–83.6 | 37.9 ± 38.2 | 33.2–42.6 | ALT (IU/L) | 4–36 | 45.6 ± 49.9 | 30.2–60.9 | 35.2 ± 45.8 | 29.6–40.8 | Cl (mmol/L) | 98–107 | 101.5 ± 4.7 | 99.4–103.6 | 101.1 ± 4.4 | 100.4–101.7 | Na (mmol/L) | 135–148 | 136 ± 3.4 | 134.8–137.8 | 137.7 ± 3.4 | 137.1–138.2 | K (mmol/L) | 3.5–5.3 | 4.2 ± 0.6 | 3.9–4.4 | 4.2 ± 0.4 | 4.1–4.3 | Creatinine (mg/dL) | 0.4–1.4 | 0.96 ± 0.43 | 0.83–1.1 | 1.0 ± 1.5 | 0.8–1.2 | BUN (mg/dL) | 7–18 | 12.4 ± 5.6 | 10.6–14.1 | 11.7 ± 5.3 | 11.0–12.3 |
|
|